Non Applicability of Reg 27(2) of SEBI (LODR) Regulations, 2015 for quarter ended 30th June, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals has told BSE that it does not need to file a quarterly Corporate Governance Report for Q1 FY26 (quarter ended 30 June 2025). The company's paid-up equity share capital is Rs. 4.60 crore and net worth is Rs. 4.83 crore as on 31 March 2025, both below the SEBI thresholds of Rs. 10 crore and Rs. 25 crore under Regulation 15(2). Because of this, the company qualifies for exemption from the Corporate Governance compliance requirements listed under Reg. 27(2). A Practicing Company Secretary (Alpi Nehra & Associates) has certified these figures. Over the last three years, paid-up capital has stayed flat at Rs. 4.60 crore, while net worth has slipped from Rs. 5.34 crore (FY23) to Rs. 5.54 crore (FY24) to Rs. 4.83 crore (FY25).
This is a routine compliance exemption filing and is neutral for shareholders — the company is simply too small (by capital and net worth) to be required to submit detailed quarterly governance reports. The declining net worth trend over three years is a mild watchpoint but not a red flag from this document alone.